Sepsis Clinical Trial
Official title:
Compensatory Reserve Index as a Hemodynamic Status Evaluation Tool in Patients
The investigators will use the Compensatory Reserve Index (CRI) device to monitor
hemodynamic status of patients in the hospital. CRI values of patients will be monitored
during their care in order to verify the compliance of the values to the physiological
condition. During the protocol investigators will document patients injuries, life-saving
procedures performed, response to treatment as well progress to systemic inflammatory
response syndrome (SIRS) and sepsis.
The indices measured in the study will not be a consideration when handling patients. The
medical team will not be exposed to metrics measured.
Assessment of patients in the emergency department, ICU or surgical department can be a
challenging process. This assessment includes collecting data regarding injury mechanism,
vital signs, and physical examination findings before proceeding to other ways of evaluating
the patient.
These data are then integrated in an attempt to form an accurate patient status and to
determine the urgency of treatment and evacuation to the next echelon of care when
necessary. When caring for multiple casualties, this process takes on an even greater
importance because the care of one patient can delay the care of others.
Triage and monitoring of patients consists of several vital sign measurements including
blood pressure, oxygen saturation, and heart rate. These measurements show varying
correlation with patient survival, Injury Severity Score, and the need for life-saving
intervention. The most significant disadvantage of their use as part of patient triage is
that they are all retrospective by nature, and a change in these indices occur only after
substantial hemodynamic compromise and failure of compensatory mechanisms when life-saving
interventions might be too late.
Because of the limitations inherent to these vital signs, several calculated indices have
been suggested in an attempt to integrate a few vital signs into more sensitive metrics for
prediction of patient outcomes. The most frequently described metric is shock index (SI),
which is calculated as the ratio between heart rate and systolic blood pressure (normal
values, 0.5 Y 0.7), and has demonstrated superiority over other indices. Heart rate
variability has also been frequently suggested as a calculated vital sign, but its clinical
utility in the acute blood loss setting has proven to be limited as a result of its high
interpatient and intrapatient variability.
The Compensatory Reserve Index (CRI) represents a new paradigm for measuring the
physiological reserve of integrated cardiopulmonary mechanisms (e.g., tachycardia,
vasoconstriction, breathing) that compensate for reduced central blood volume. Advanced
sensor technologies such as photoplethysmography enable noninvasive recordings of analog
arterial waveforms. Using a model that induces stepwise reduction of central blood volume
(lower body negative pressure [LBNP]) in volunteering young healthy human test subjects,
through application of negative pressure to the lower body, feature-extraction and
machine-learning techniques were used to reveal subtle changes in waveform features that are
associated with a declining volume. This approach enables simultaneous abstraction and
normalization of various characteristics of the arterial waveform. As such, the CRI aims to
reflect the capacity of all factors contributing to physiological compensatory mechanisms,
including compensatory reflexes, various muscle contractions, and respirations, among
others. Compensatory Reserve Index values range from 0 (complete decompensation) to 1 (full
compensatory reserve available). The device itself is compact, light, and can be placed on
the patient's finger, and the test can be performed within 30 s, making the measurement of
CRI theoretically feasible in almost any setting. The approach was designed to prospectively
identify ongoing loss of central blood volume and thus estimate the point at which
individuals will experience hemodynamic decompensation (onset of shock) well in advance
compared with changes in standard or "legacy" vital signs.
The CRI has been shown to correlate with central blood volume changes in human subjects in
laboratory conditions however, few published data regarding its use in other experimental
models or its ability to detect actual blood loss exist. The current investigation
represents the first effort to apply a small pulse oximeter unit to test the CRI on human
subjects admitted to hospital.
The purpose of the study is to test the hypothesis that a novel noninvasive CRI monitoring
algorithm would demonstrate greater sensitivity and specificity compared with standard vital
signs for identifying patients with blood loss, SIRS, sepsis thus enabling appropriate
measures to be taken.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |